tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARCT Stock Latest News

FIG, BLSH, ETOR, TEM: Wood Expands Bets in Tech and Fintech, Trims Stake in Tempus AI Stock
Market NewsFIG, BLSH, ETOR, TEM: Wood Expands Bets in Tech and Fintech, Trims Stake in Tempus AI Stock
13h ago
FIG
TEM
Arcturus Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Arcturus Therapeutics assumed with a Buy at H.C. Wainwright
10d ago
ARCT
Arcturus Therapeutics’ Earnings Call Highlights Progress and Optimism
PremiumCompany Announcements
Arcturus Therapeutics’ Earnings Call Highlights Progress and Optimism
14d ago
ARCT
Arcturus Therapeutics’ COVID-19 Vaccine Approved in Japan
PremiumCompany Announcements
Arcturus Therapeutics’ COVID-19 Vaccine Approved in Japan
16d ago
8K
ARCT
Arcturus Therapeutics price target lowered to $54 from $63 at Leerink
PremiumThe Fly
Arcturus Therapeutics price target lowered to $54 from $63 at Leerink
23d ago
ARCT
Arcturus Therapeutics: Promising Prospects with ARCT-032 and Billion-Dollar Market Potential
PremiumRatingsArcturus Therapeutics: Promising Prospects with ARCT-032 and Billion-Dollar Market Potential
23d ago
ARCT
Positive Outlook and Buy Rating for Arcturus Therapeutics Amid Promising Pipeline Developments and Strong Financial Position
Premium
Ratings
Positive Outlook and Buy Rating for Arcturus Therapeutics Amid Promising Pipeline Developments and Strong Financial Position
1M ago
ARCT
Arcturus Therapeutics: Promising Developments and Strong Financial Health Justify Buy Rating
Premium
Ratings
Arcturus Therapeutics: Promising Developments and Strong Financial Health Justify Buy Rating
1M ago
ARCT
Arcturus Therapeutics price target raised to $49 from $47 at Citi
PremiumThe Fly
Arcturus Therapeutics price target raised to $49 from $47 at Citi
1M ago
ARCT
Arcturus Therapeutics price target lowered to $42 from $45 at Wells Fargo
PremiumThe Fly
Arcturus Therapeutics price target lowered to $42 from $45 at Wells Fargo
1M ago
ARCT
Optimistic Buy Rating for Arcturus Therapeutics Driven by Promising Developments in Cystic Fibrosis and COVID-19 Vaccine Programs
PremiumRatings
Optimistic Buy Rating for Arcturus Therapeutics Driven by Promising Developments in Cystic Fibrosis and COVID-19 Vaccine Programs
1M ago
ARCT
Arcturus Therapeutics Reports Q2 2025 Earnings and Pipeline Progress
PremiumCompany Announcements
Arcturus Therapeutics Reports Q2 2025 Earnings and Pipeline Progress
1M ago
ARCT
Arcturus Therapeutics reports Q2 EPS (34c), consensus (87c)
PremiumThe FlyArcturus Therapeutics reports Q2 EPS (34c), consensus (87c)
1M ago
ARCT
Is ARCT a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARCT a Buy, Before Earnings?
1M ago
ARCT
Private Markets: Canva draws attention as IPO candidate following Figma debut
Premium
The Fly
Private Markets: Canva draws attention as IPO candidate following Figma debut
1M ago
BA
CAI
Arcturus Therapeutics: Strategic Focus Beyond mRNA Vaccines Drives Buy Rating
PremiumRatings
Arcturus Therapeutics: Strategic Focus Beyond mRNA Vaccines Drives Buy Rating
1M ago
ARCT
Arcturus Therapeutics: Promising mRNA Developments and High Upside Potential Justify Buy Rating
PremiumRatings
Arcturus Therapeutics: Promising mRNA Developments and High Upside Potential Justify Buy Rating
2M ago
ARCT
3 Best Stocks to Buy Now, 7/7/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/7/2025, According to Top Analysts
2M ago
FC
ARCT
Arcturus Therapeutics price target raised to $35 from $32 at Scotiabank
PremiumThe Fly
Arcturus Therapeutics price target raised to $35 from $32 at Scotiabank
2M ago
ARCT
Positive Outlook for ARCT-810: Safety and Efficacy Indicators Justify Buy Rating
PremiumRatingsPositive Outlook for ARCT-810: Safety and Efficacy Indicators Justify Buy Rating
2M ago
ARCT
Positive Outlook for Arcturus Therapeutics: Promising mRNA Technology and Competitive Edge in Urea-Cycle Disorders
Premium
Ratings
Positive Outlook for Arcturus Therapeutics: Promising mRNA Technology and Competitive Edge in Urea-Cycle Disorders
2M ago
ARCT
Positive Outlook for Arcturus Therapeutics Amid Promising Developments in ARCT-810 and ARCT-032 Programs
Premium
Ratings
Positive Outlook for Arcturus Therapeutics Amid Promising Developments in ARCT-810 and ARCT-032 Programs
3M ago
ARCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >